US Broker Ratings

10x Genomics, Inc. (TXG) Stock Analysis: Unpacking a 29% Potential Upside in the Healthcare Sector

Investors looking to capitalize on the innovative edge of the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing opportunity. This Pleasanton, California-based life science technology company is..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Healthcare Innovator with 22.64% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is emerging as a strong contender in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.93 billion,..

Select Medical Holdings Corp (SEM) Stock Analysis: Strong Buy Ratings Signal 36% Upside Potential

Select Medical Holdings Corporation (NYSE: SEM), known for its extensive network of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics, has been making waves in the healthcare sector...

Certara, Inc. (CERT) Stock Analysis: Unveiling a 20% Upside Potential in Healthcare Innovation

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, is making waves in the health information services industry with its cutting-edge technology-enabled services and software products. As a..

Tarsus Pharmaceuticals (TARS) Stock Analysis: A 9% Upside with Strong Buy Ratings

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is drawing significant attention in the biotechnology sector, particularly due to its innovative focus on eye care therapeutics. The Irvine, California-based company is emerging as..

NeoGenomics, Inc. (NEO) Stock Analysis: A Healthcare Diagnostics Player with a 7% Upside Potential

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the healthcare sector, operates a sophisticated network of cancer-focused testing laboratories across the United States and the United Kingdom. With a current..

Healthcare Services Group, Inc. (HCSG): Investor Outlook on a Robust 15% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) is emerging as a crucial player within the healthcare sector, particularly in the specialized niche of medical care facilities. This Pennsylvania-based company, with a..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring a 77% Potential Upside Amidst Clinical Advancements

Viridian Therapeutics, Inc. (NASDAQ: VRDN) stands as a promising player in the biotechnology sector, capturing the interest of investors with its focus on developing transformative treatments for serious and rare..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating the Challenges with an 18.39% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specifically within the medical devices industry, is currently navigating a challenging market environment. With a market capitalization..

89bio, Inc. (ETNB) Stock Analysis: Potential 97.97% Upside in the Biotech Arena

89bio, Inc. (NASDAQ: ETNB), a dynamic player in the biotechnology sector, is garnering significant attention from investors due to its promising potential upside and robust pipeline. With a market capitalization..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Potential 38% Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might find Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) an intriguing candidate, particularly given its potential upside of 38.24%. With a current market capitalization..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a Biotech with Strong Buy Ratings and Promising Clinical Pipeline

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising name in the biotechnology sector, has caught the attention of investors with its innovative approach to tackling cardiorenal diseases driven by dysregulated aldosterone...

AtriCure, Inc. (ATRC)

⚠️ No article content returned.

..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Potential Upside in Healthcare Innovation

Azenta, Inc. (NASDAQ: AZTA) is positioned at the intersection of healthcare innovation, offering a range of biological and chemical compound sample management solutions. With a market capitalization of $1.4 billion,..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Promising 35% Upside in the Healthcare Sector

Establishment Labs Holdings Inc (NASDAQ: ESTA) is carving out a significant niche in the healthcare sector with its innovative medical devices tailored for aesthetic and reconstructive plastic surgeries. Headquartered in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Unveiling an 84.95% Potential Upside Amid Biotech Innovations

Ocular Therapeutix, Inc. (NASDAQ: OCUL) stands out in the biotechnology sector by leveraging its innovative bioresorbable hydrogel-based formulation technology to tackle retinal diseases and other ocular conditions. The company’s focus..

Immunocore Holdings plc (IMCR) Stock Analysis: Navigating a Potential 92% Upside in the Biotech Arena

Immunocore Holdings plc (NASDAQ: IMCR), a compelling player within the biotechnology sector, has caught the attention of the investment community with its promising pipeline of immunotherapies and a significant potential..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 38% Upside Potential in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY) represents a promising investment opportunity in the healthcare sector, particularly for those focusing on innovative fertility and family-building solutions. With a market capitalization of $1.76 billion,..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Highs of a $2.54 Billion Market Cap with a Potential Downside

GRAIL, Inc. (NASDAQ: GRAL), a prominent player in the healthcare sector, specifically in diagnostics and research, has been capturing investor attention with its pioneering multi-cancer early detection tests. As the..

National HealthCare Corporation (NHC): Unpacking the Growth Potential in a Thriving Healthcare Sector

National HealthCare Corporation (NYSE: NHC), a key player in the healthcare sector, stands out with its comprehensive range of services spanning skilled nursing facilities, assisted and independent living facilities, and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds